Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bioxytran Inc

BIXT
Current price
0.08 USD -0.0019 USD (-2.32%)
Last closed 0.082 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange OTCQB
Capitalization 6 711 741 USD
Yield for 12 month -58.97 %
1Y
3Y
5Y
10Y
15Y
BIXT
21.11.2021 - 28.11.2021

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was founded in 2008 and is headquartered in Needham, Massachusetts. Address: 75 2nd Avenue, Needham, MA, United States, 02494

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.71 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures BIXT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 405 401 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -1571.42 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 2.71 USD
Revenue TTM
Book Value -0.002 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.02 USD
Diluted Eps TTM -0.02 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BIXT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BIXT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 27.08.2018
Dividend Date 22.08.2018

Stock Valuation BIXT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 706.6372
Price Sales TTM 532.5585
Enterprise Value EBITDA -5.7227
Price Book MRQ

Financials BIXT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIXT

For 52 weeks

0.071 USD 0.23 USD
50 Day MA 0.1 USD
Shares Short Prior Month
200 Day MA 0.12 USD
Short Ratio
Shares Short
Short Percent